申请人:Novo Nordisk A/S
公开号:US06555577B1
公开(公告)日:2003-04-29
The present invention relates to compounds of the general formula (I)
The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
本发明涉及一般式(I)的化合物。
这些化合物在治疗和/或预防由核受体介导的疾病中具有用途,特别是过氧化物酶体增殖激活受体(PPAR)。